NTN3
Netrin-3
Also known as: NET3_HUMAN, NTN2L
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00634
- Gene
- NTN3
- Ensembl
- ENSG00000162068
- Chromosome
- 16
- Canonical length
- 580 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in brain
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in Golgi apparatus and extracellular region. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
580 residues, UniProt reviewed canonical sequence.
>O00634|NTN3
1 MPGWPWGLLL TAGTLFAALS PGPPAPADPC HDEGGAPRGC VPGLVNAALG REVLASSTCG
61 RPATRACDAS DPRRAHSPAL LTSPGGTASP LCWRSESLPR APLNVTLTVP LGKAFELVFV
121 SLRFCSAPPA SVALLKSQDH GRSWAPLGFF SSHCDLDYGR LPAPANGPAG PGPEALCFPA
181 PLAQPDGSGL LAFSMQDSSP PGLDLDSSPV LQDWVTATDV RVVLTRPSTA GDPRDMEAVV
241 PYSYAATDLQ VGGRCKCNGH ASRCLLDTQG HLICDCRHGT EGPDCGRCKP FYCDRPWQRA
301 TARESHACLA CSCNGHARRC RFNMELYRLS GRRSGGVCLN CRHNTAGRHC HYCREGFYRD
361 PGRALSDRRA CRACDCHPVG AAGKTCNQTT GQCPCKDGVT GLTCNRCAPG FQQSRSPVAP
421 CVKTPIPGPT EDSSPVQPQD CDSHCKPARG SYRISLKKFC KKDYAVQVAV GARGEARGAW
481 TRFPVAVLAV FRSGEERARR GSSALWVPAG DAACGCPRLL PGRRYLLLGG GPGAAAGGAG
541 GRGPGLIAAR GSLVLPWRDA WTRRLRRLQR RERRGRCSAALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NTN3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 0.3 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 0.3 nTPM
- testis: 0.3 nTPM
- amygdala: 0.2 nTPM
- cerebral cortex: 0.2 nTPM
- hypothalamus: 0.2 nTPM
- liver: 0.2 nTPM
Single-cell type
- hepatocytes: 0.3 nCPM
- cardiomyocytes: 0.1 nCPM
- müller glia: 0.1 nCPM
- undifferentiated spermatogonia: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 11 nTPM
- amygdala: 9.5 nTPM
- medulla oblongata: 9.5 nTPM
- midbrain: 9.5 nTPM
- thalamus: 8.7 nTPM
- spinal cord: 8.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.28
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Netrin domain
- Laminin-type EGF domain
- Laminin, N-terminal
- Tissue inhibitor of metalloproteinases-like, OB-fold
- Netrin module, non-TIMP type
- Laminin/Netrin Extracellular Matrix
- Laminin/attractin/netrin-like, EGF domain
- Laminin EGF domain
- Laminin N-terminal (Domain VI)
- UNC-6/NTR/C345C module
- Laminin/attractin EGF domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NTN3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NTN3 as an antibody target. Whether an autoantibody or antibody against NTN3 could matter depends on whether native NTN3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NTN3 is annotated as secreted, so native NTN3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NTN3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...